Galapagos NV
GLPG
$29.08
Share price
0.59%
Change (1 day)
-22.31%
Change (1 year)
Categories
Operating Margin for Galapagos NV (GLPG)
Operating Margin as of April 2024 (TTM): -26.07%
According to Galapagos NV's latest financial reports and stock price the company's current Operating Margin is -26.07%. At the end of 2022 the company had an Operating Margin of -42.58%.
Operating Margin history for Galapagos NV from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -42.58% | 67.84% |
| 2021 | -25.37% | -60.85% |
| 2020 | -64.80% | -464.88% |
| 2019 | 17.76% | -275.61% |
| 2018 | -10.11% | -88.87% |
| 2017 | -90.89% | -317% |
| 2016 | 41.88% | -113.85% |
| 2015 | -302.37% | 495.86% |
| 2014 | -50.75% | 524.23% |
| 2013 | -8.13% | 115.02% |
| 2012 | -3.78% | -89.25% |
| 2011 | -35.17% | -7422.47% |
| 2010 | 0.48% | -73.46% |
| 2009 | 1.81% | -107.54% |
| 2008 | -24.00% | -29.67% |
| 2007 | -34.13% | -3.97% |
| 2006 | -35.54% | -39.93% |
| 2005 | -59.17% | 28.98% |
| 2004 | -45.88% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -187.76% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -159.84% | 🇺🇸 USA |
 AbbVie ABBV | 18.65% | -171.54% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -169.85% | 🇫🇷 France |
 Merck MRK | 27.73% | -206.37% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -121.60% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 22.54% | -186.46% | 🇬🇧 UK |
 Fortress Biotech
FBIO | -281.82% | 981.01% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -21.25% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.